Indonesia Issues Decree To Override Patents On HIV Medicines.

Reuters (10/12, Bigg) reported that Indonesia's government is acting to override patents on HIV medications. The move highlights a trend by Asian nations to allow local production of cheap generic medicine. Last month, President Susilo Bambang Yudhoyono issued a decree authorizing government use of patents for seven hepatitis B and HIV/AIDS medicines held by companies, including GlaxoSmithKline, Merck & Co, Bristol-Myers Squibb, Gilead, and Abbott. The decree said the government implemented the measures to "meet the urgent need for antiviral and antiretroviral treatments." The international trade association, which represents major pharmaceutical companies said the move set "a negative precedent."


from DIA Daily

DIA Daily is a digest of the most important news selected from thousands of sources by the editors of BulletinHealthcare. The presence of content or advertising does not endorse, nor imply endorsement of, any products or services by the Drug Information Association. Neither BulletinHealthcare nor the Drug Information Association is liable for the use of or reliance on any information contained in this briefing.

View BulletinHealthcare's privacy policy.
Drug Information Association | 800 Enterprise Road, Suite 200 | Horsham, PA 19044
Copyright © 2012 by BulletinHealthcare | 11190 Sunrise Valley Drive, Suite 130 | Reston, VA 20191